United States · FDA National Drug Code directory
Liraglutide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0480-7250_4df44cd9-cb11-46b6-ba6c-88ff963ec414
- Product NDC
- 0480-7250
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Liraglutide
- Labeler
- Teva Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250828 / 20270930
Source-listed ingredients
- LIRAGLUTIDE — 6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 SYRINGE, PLASTIC in 1 CARTON (0480-7250-46) / 3 mL in 1 SYRINGE, PLASTIC · 0480-7250-46
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →